Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.

Myriam Adam; Vanda Pogacic; Marina Bendit; Richard Chappuis; Martijn C Nawijn; Justus Duyster; Casey J Fox; Craig B Thompson; Jan Cools; Juerg Schwaller

doi:10.1158/0008-5472.CAN-05-2309

Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.

Identifier:nobleid.org/w1/20260515/19EB70F2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/19EB70F2.svg?ark=w1%2F20260515%2F19EB70F2)](https://nobleid.org/work/w1/20260515/19EB70F2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.

Identifier:nobleid.org/w1/20260515/19EB70F2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/19EB70F2.svg?ark=w1%2F20260515%2F19EB70F2)](https://nobleid.org/work/w1/20260515/19EB70F2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work